Wednesday, November 18, 2026
Play Store.png
Observer Logo.webp
E-Paper
Wednesday, November 18, 2026

Antibiotic Resistance Crisis worsens in Pakistan as WHO warns of over 200,000 Deaths Every Year

ISLAMABAD — A silent health crisis is deepening across Pakistan as antibiotics that once saved countless lives are increasingly losing their effectiveness. With drug-resistant infections linked to over 200,000 deaths every year, World Health Organization warned that the misuse of antibiotics today could turn even common infections into deadly threats tomorrow.

The alarming situation prompted the World Health Organization and Pakistan’s National Institute of Health (NIH) to issue an urgent appeal for coordinated action across healthcare, agriculture, livestock and environmental sectors. According to estimates shared by the health organizations, approximately 40,000 people die annually in Pakistan as a direct consequence of antimicrobial resistance (AMR), while resistant infections are associated with more than 160,000 additional deaths.

The figures indicate that over 200,000 deaths in Pakistan every year are associated with antimicrobial resistance, highlighting the scale of a crisis that experts warn could worsen considerably in the coming decades.

The warning came as NIH and WHO joined the UK Health Security Agency (UKHSA), the Food and Agriculture Organization (FAO), students, civil society representatives and other partners to launch World Antimicrobial Resistance Awareness Week in Islamabad.

An awareness walk marked the beginning of the campaign, bringing together officials and participants determined to draw attention to the potentially devastating consequences of antibiotic misuse. The campaign, organized under the international theme “One Health, One Action: Prevent AMR Now,” delivered a powerful message that abusing antibiotics today could leave humanity without effective protection against infections tomorrow.

Health authorities have warned that Pakistan could face an even greater antimicrobial resistance crisis over the next two decades if unnecessary antibiotic consumption and weak infection control practices continue. Projections suggest that by 2050, the number of deaths directly caused by antimicrobial resistance in Pakistan could climb to approximately 63,000 annually.

Antibiotic awareness Week A call for responsible use in Pakistan

At the same time, the total number of deaths associated with resistant infections could reach 262,000 per year. These figures represent different measures of the AMR burden, with deaths directly attributable to resistance included within the wider category of associated deaths.

The projected increase raises serious concerns about the future effectiveness of medicines used to treat bacterial infections and protect patients undergoing medical procedures. Experts fear that without stronger intervention, infections that modern medicine has successfully treated for decades could once again pose life-threatening risks.

Antimicrobial resistance occurs when bacteria, viruses, fungi and parasites develop the ability to survive medicines that would ordinarily control or eliminate them. As microorganisms become resistant, infections can persist despite treatment, forcing healthcare professionals to rely on alternative medicines that may be more expensive, less accessible or less effective.

Health authorities believe that the widespread misuse of antibiotics has become a major factor behind the accelerating crisis. In Pakistan, antibiotics are frequently obtained without a prescription, taken for illnesses that do not require them or used incorrectly without appropriate medical guidance.

Antimicrobial medicines are also used in livestock farming, veterinary treatment and agricultural activities, creating additional opportunities for resistant microorganisms to emerge and spread. Inadequate sanitation, improper disposal of healthcare waste, contaminated wastewater and poor infection prevention practices further complicate efforts to control resistance.

NIH Chief Executive Officer Dr. Muhammad Salman said addressing antimicrobial resistance requires a comprehensive national response that recognizes the connection between human health, animal health and the environment. He identified irrational antibiotic prescribing, over-the-counter sales of antimicrobial medicines and insufficient infection prevention measures as key factors contributing to the problem in Pakistan.

WHO Representative in Pakistan Dr. Luo Dapeng delivered a particularly alarming assessment of the human toll of antimicrobial resistance. Illustrating the magnitude of the crisis, he warned that during a five-minute speech, approximately two people in Pakistan could lose their lives due to causes directly attributable to or associated with antimicrobial resistance.

He emphasized that many such deaths could be prevented through timely action, stronger healthcare systems and responsible antibiotic use.

The awareness campaign also brought attention to Pakistan’s National Action Plan 2.0 on Antimicrobial Resistance, which outlines measures aimed at reducing the spread and impact of resistant infections. A major priority under the strategy is improving surveillance systems to identify and monitor antimicrobial resistance among humans and animals.

The plan also emphasizes strengthening public awareness, educating medical and veterinary professionals and introducing better infection prevention and control practices in healthcare facilities. Health officials believe that more effective surveillance and improved diagnostic capabilities can help doctors identify infections accurately and avoid unnecessary antimicrobial treatment.

As World Antimicrobial Resistance Awareness Week gets underway, WHO, NIH and UKHSA have urged policymakers, medical practitioners, veterinarians, farmers and ordinary citizens to recognize the seriousness of the threat. They called for stronger efforts to discourage unnecessary antibiotic use, improve prescribing practices and prevent the spread of infections in hospitals and communities.

The organizations emphasized that antibiotics should be taken only when prescribed appropriately by qualified healthcare professionals and should not be used to treat viral illnesses such as colds and influenza.

Get Alerts